Logo is a trademark of Nutramax Laboratories, Inc. All rights reserved.
- One of our newest discoveries and our MOST POTENT option for Active People with joint discomfort.
- Contains the FULL CLINICAL STRENGTH of active ingredients - compare to other brands
- ASU (Avocado/Soybean Unsaponifiables) is derived from avocados and soybeans and has been shown in laboratory research to inhibit components that result in cartilage breakdown.
- Ingredients shown in laboratory cell culture studies to work better than just the combination of glucosamine + chondroitin sulfate**
- Contains decaffeinated green tea for antioxidant health benefits.
US Patent Nos. 6,797,289 and 5,587,363
Additional Patents Pending
What is Cosamin® ASU?
Cosamin® ASU is an advanced proprietary formulation that combines NMX1000® avocado/soybean unsaponifiables (ASU) with Cosamin's FCHG49® glucosamine and pharmaceutical-grade TRH122® sodium chondroitin sulfate.
For over a decade, Cosamin® DS has served as the premium joint health supplement on the market. By combining the exclusive ingredients found in Cosamin DS with ASU, Nutramax Laboratories, Inc. has made the best even better.
Cosamin ASU is a dual synergistic formula: its specific combination of glucosamine and sodium chondroitin sulfate have demonstrated synergy in stimulating cartilage production,1 while ASU also acts synergistically with glucosamine.
What is ASU and how does it work?
ASU (avocado/soybean unsaponifiables) is derived from avocados and soybeans. A potent ingredient demonstrated to protect cartilage which leads to improved joint function, ASU complements the effects of the other ingredients. While working through their own primary mechanisms of action, ASU, glucosamine and chondroitin sulfate together deliver comprehensive joint health support. Our trademarked glucosamine hydrochloride, chondroitin sulfate, and avocado/soybean unsaponifiables together were shown in cell studies to be better than the combination of glucosamine and chondroitin sulfate at inhibiting expression of several agents involved in cartilage breakdown.
Reduces the expression of inflammatory markers that are associated with joint discomfort and the process of cartilage breakdown in the joints.^
A "building block" molecule produced by the body for the production of a variety of structures essential to joint health.
Inhibits enzymes responsible for the breakdown of cartilage and stimulates cartilage cells to increase the production of cartilage components necessary for the maintenance of healthy joints.^
^demonstrated in vitro (laboratory cell culture) research